The Rosen Law Firm Files Securities Fraud Class Action Charging Zynex, Inc. f/k/a Zynex Medical Holdings, Inc. With

NEW YORK, NY, Apr 07 (MARKET WIRE) --
The Rosen Law Firm today announced that it has filed a securities fraud
class action lawsuit on behalf of all purchasers of Zynex, Inc. (OTCBB:
ZYXI) formerly known as Zynex Medical Holdings, Inc. (OTCBB: ZYNX)
(collectively "Zynex" or the "Company") securities between May 21, 2008
and March 31, 2009 inclusive (the "Class Period").

To join the Zynex class action, go to the website at
http://www.rosenlegal.com or call Laurence Rosen, Esq. or Phillip Kim,
Esq. toll-free at 866-767-3653 or email lrosen@rosenlegal.com or
pkim@rosenlegal.com for information on the class action.

The case is pending in the United States District Court for the District
of Colorado as case no. 09-CV-780. You can obtain a copy of the complaint
from the clerk of court or you may contact counsel for plaintiffs Laurence
Rosen, Esq. or Phillip Kim, Esq. toll-free at 866-767-3653 or email
lrosen@rosenlegal.com or pkim@rosenlegal.com.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS
CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU
MAY ALSO REMAIN AN ABSENT CLASS MEMBER. YOU MAY ALSO RETAIN COUNSEL OF
YOUR CHOICE.

The Complaint charges Zynex, its CEO Sandgaard, and CFO Allison (the
"Defendants") with violations of the Sections 10(b) and 20(a) of the
Securities Exchange Act of 1934 in connection with Zynex's issuance of
materially false financial statements to the investing public during the
Class Period. According to the Complaint, the Defendants, in violation of
the Generally Accepted Accounting Principles and Zynex's own internal
polices, misstated the Company's reported net revenues and accounts
receivable for the first three quarters of fiscal 2008.

On April 1, 2009 Zynex announced that its unaudited financial statements
and press releases issued on results for the first three quarters of 2008
can no longer be relied upon and would have to issue restated financial
results to reflect adjustments to accounts receivable and net revenue for
such periods. The Company announced that it believed the cumulative impact
of these adjustments would be $5.1 million. This adverse news caused
Zynex's stock price to fall dramatically, injuring Zynex shareholders.

A class action lawsuit has already been filed on behalf of Zynex
shareholders. If you wish to serve as lead plaintiff, you must move the
Court no later than June 8, 2009. If you wish to join the litigation or to
discuss your rights or interests regarding this class action, please
contact plaintiff's counsel, Laurence Rosen, Esq. or Phillip Kim, Esq. of
The Rosen Law Firm toll free at 866-767-3653 or via e-mail at
lrosen@rosenlegal.com or pkim@rosenlegal.com.

The Rosen Law Firm represents investors throughout the United States,
concentrating its practice in securities class actions and shareholder
derivative litigation.

Contact:
Laurence Rosen, Esq.
Email Contact
Phillip Kim, Esq.
Email Contact
The Rosen Law Firm P.A.
Tel: (212) 686-1060
Weekends Tel: (917) 797-4425
Toll Free: 1-866--767-3653
Fax: (212) 202-3827
350 5th Avenue, Suite 5508
New York, New York 10118
www.rosenlegal.com

Copyright 2009, Market Wire, All rights reserved.

-0-